Join Us in Advancing Safe Medication Disposal on National Prescription Drug Take-Back Day

As National Prescription Drug Take-Back Day approaches on October 26, Inmar highlights the importance of safe medication disposal to prevent misuse. Since 2017, Inmar’s Consumer Drug Take-Back Program has collected over 3 million pounds of unused medications. With more than 6,400 collection kiosks nationwide, Inmar continues to provide convenient disposal options, helping reduce the risk of prescription drug misuse and protect communities. Businesses and pharmacies are encouraged to support responsible disposal efforts for a safer, healthier environment.

• Read more about Join Us in Advancing Safe Medication Disposal on National Prescription Drug Take-Back Day

Automated Deductions Management for CPGs

Deductions, also known as chargebacks, happen when retailers or distributors don't pay their invoices in full to CPGs and manufacturers — and the $ can add up fast! That’s why it’s so important to assess them quickly, see if they’re actually valid, and determine if you should push to get that money back. 

• Read more about Automated Deductions Management for CPGs

Inmar Intelligence Hosts 9th Semi-Annual Drug Take-Back Event in Winston-Salem

Partnering with Novant Health and Forsyth County Sheriff’s Office, Inmar furthers commitment to community-wide safe disposal of medications

• Read more about Inmar Intelligence Hosts 9th Semi-Annual Drug Take-Back Event in Winston-Salem

How DSCSA Boosts Crisis Resilience: Strengthening Pharmacies and Hospitals

This article explores how the Drug Supply Chain Security Act (DSCSA) enhances crisis resilience for pharmacies and hospitals by improving product traceability. It highlights the critical role DSCSA plays during supply chain disruptions caused by natural disasters, such as Hurricane Helene, enabling healthcare providers to maintain access to essential medications and ensure patient safety. By leveraging DSCSA’s serialized data and chain of custody insights, pharmacies and hospitals can proactively address challenges and strengthen their operational preparedness.

• Read more about How DSCSA Boosts Crisis Resilience: Strengthening Pharmacies and Hospitals

FTC versus the PBMs: The Battle to Lower Insulin Prices and Reform PBMs

The FTC has filed a lawsuit against major pharmacy benefit managers (PBMs), accusing them of inflating insulin prices through anticompetitive practices that harm patients. This legal battle could lead to significant PBM reforms, ensuring fair pricing for essential medications like insulin. The lawsuit highlights the rising cost of insulin, forcing many patients to ration their medication or go without due to high out-of-pocket expenses. If successful, the case could set a new precedent in holding PBMs accountable and improving access to affordable medications for millions of patients.

• Read more about FTC versus the PBMs: The Battle to Lower Insulin Prices and Reform PBMs

2024 Mid-Year Promotions Trends & Shopper Insights webinar

Consumers are overwhelmed. Will your marketing strategies cut through the noise and support them in their quest for savings? Compared to a year ago, half of consumers are putting more effort into planning their grocery trips. Are you reaching them in the right moments on the right channels as they build their lists?  Shoppers today expect more from the brands and retailers they engage with. How can you earn their favor and their business?

• Read more about 2024 Mid-Year Promotions Trends & Shopper Insights webinar

Delaying DSCSA Enforcement: The Right Decision for all the Right Reasons

Brian Nightengale, EVP and President of Healthcare at Inmar Intelligence, discusses the FDA’s recent decision to delay DSCSA enforcement. The delay offers pharmaceutical supply chain partners more time to fully achieve compliance and address operational challenges related to electronic interoperability and product traceability. Nightengale praises the decision as a thoughtful and proactive move to prevent disruptions in medication distribution while maintaining focus on patient safety and the integrity of the supply chain. He urges industry stakeholders to continue prioritizing efforts toward full DSCSA compliance.

• Read more about Delaying DSCSA Enforcement: The Right Decision for all the Right Reasons

On-Demand Webinar: The Power of Personalization & The Consumer Effect

Featuring PepsiCo Foods and Forrester Research Guest Speakers Personalization is more than just a trend; it’s one of the most powerful ways to improve consumer experiences and brand loyalty. As consumers increasingly expect tailored interactions across channels, brands are under pressure to deliver relevant, value-driven experiences. Meeting these expectations requires a strategic approach, combining data, creativity, and a deep understanding of consumer needs. 

• Read more about On-Demand Webinar: The Power of Personalization & The Consumer Effect

You Previously Qualified for a Small Dispenser DSCSA Exemption. Now What?

This article, originally published in Pharmacy Times, explores the DSCSA exemption for small dispensers and outlines their current and future regulatory obligations. It highlights the importance of staying compliant with key DSCSA requirements, including verifying trading partner licenses, maintaining product tracing documentation, and preparing for full electronic interoperability by the 2026 deadline.

• Read more about You Previously Qualified for a Small Dispenser DSCSA Exemption. Now What?